Table 2 Clinical data of CRC patients. CRP, C-reactive protein; CA 19 − 9, cancer antigen 19 − 9; CEA, Carcinoembryonic antigen; NA, Not applicable
Characteristic | CRC patients (n = 30) | Control (n = 15) | P value | |
|---|---|---|---|---|
Sex | Male | 18 (60%) | 8 (54%) | NA |
Female | 12 (40%) | 7 (46%) | NA | |
Age | Mean ± SD | 50.13 ± 10.48 | 53.80 ± 14.02 | 0.324 |
Range | 31–68 | 29–72 | NA | |
Stage | T2N1 | 9 (30%) | NA | NA |
T3N1 | 4 (13.3%) | NA | NA | |
T3N2 | 2 (6.7%) | NA | NA | |
T4N0 | 3 (10%) | NA | NA | |
T4N1 | 3 (10%) | NA | NA | |
T4N2 | 9 (30%) | NA | NA | |
CRP (mg/dL) | 23.08 ± 9.62 | 1.23 ± 0.48 | < 0.001 | |
CA 19 − 9 (U/mL) | 47.06 ± 8.33 | NA | NA | |
CEA (ng/mL) | 34.24 ± 17.82 | NA | NA | |
DNA concentration in plasma (ng/µL) | Mean ± SD | 171.90 ± 61.60 | 58.79 ± 34.07 | < 0.001 |
Range | 19.62–296.31 | 12.68–126.01 | NA | |